Eversept Partners’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-51,614
Closed -$4.31M 131
2026
Q1
$4.31M Sell
51,614
-134,125
-72% -$11M 0.23% 63
2025
Q4
$17M Buy
185,739
+133,351
+255% +$12.8M 0.86% 31
2025
Q3
$4.96M Sell
52,388
-103,480
-66% -$9.74M 0.34% 49
2025
Q2
$16.3M Sell
155,868
-196,108
-56% -$18.6M 1.5% 24
2025
Q1
$31.1M Sell
351,976
-34,721
-9% -$3.56M 3.16% 9
2024
Q4
$37.1M Buy
386,697
+67,619
+21% +$6.3M 3.29% 9
2024
Q3
$26.1M Sell
319,078
-94,453
-23% -$7.29M 1.79% 16
2024
Q2
$35.6M Sell
413,531
-7,814
-2% -$631K 2.44% 13
2024
Q1
$34.4M Sell
421,345
-73,574
-15% -$5.74M 2.29% 12
2023
Q4
$32.8M Buy
494,919
+156,403
+46% +$10.8M 2.88% 10
2023
Q3
$24.7M Buy
+338,516
New +$22.9M 2.09% 12
2022
Q3
Sell
-127,043
Closed -$7.8M 80
2022
Q2
$7.8M Sell
127,043
-17,097
-12% -$1.1M 0.55% 41
2022
Q1
$9.72M Sell
144,140
-189,212
-57% -$10.2M 0.75% 37
2021
Q4
$14.7M Buy
333,352
+218,974
+191% +$12.8M 0.94% 31
2021
Q3
$7.41M Sell
114,378
-83,122
-42% -$5.77M 0.51% 48
2021
Q2
$15.9M Buy
+197,500
New +$15M 1.06% 28

Other funds holding HQY

Eversept Partners's HQY Position: Q2 2026 in Review

Eversept Partners sold out of HealthEquity (HQY) in Q2 2026, closing a stake of 51,614 shares — an estimated $4.31M sold.

Eversept Partners first reported a position in HQY in Q2 2021 and held it in 16 quarters. The position peaked at $37.1M in Q4 2024. 498 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Eversept Partners reported no remaining HealthEquity position as of Q2 2026 after selling out during the quarter.
  • Eversept Partners sold 51,614 HealthEquity shares in Q2 2026, an estimated $4.31M.
  • Eversept Partners first reported a position in HealthEquity in Q2 2021 and held it in 16 quarters.
  • Eversept Partners's HealthEquity position peaked at $37.1M in Q4 2024.
  • 498 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Eversept Partners's 13F filing for Q2 2026, filed 14 Aug 2026.